dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Rabe, Klaus F. |
dc.contributor.author | Chalmers, James |
dc.contributor.author | Miravitlles Fernández, Marc |
dc.contributor.author | Kocks, Janwillem |
dc.contributor.author | Tsiligianni, Ioanna |
dc.contributor.author | de la Hoz, Alberto |
dc.date.accessioned | 2022-06-13T13:04:43Z |
dc.date.available | 2022-06-13T13:04:43Z |
dc.date.issued | 2021-01 |
dc.identifier.citation | Rabe KF, Chalmers JD, Miravitlles M, Kocks JWH, Tsiligianni I, de la Hoz A, et al. Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO® Trials. Adv Ther. 2021 Jan;38:579–93. |
dc.identifier.issn | 1865-8652 |
dc.identifier.uri | https://hdl.handle.net/11351/7672 |
dc.description | Exacerbacions; Funció pulmonar; Tiotropi |
dc.description.sponsorship | Support for this project and the journal’s Open Access Fee were funded by Boehringer Ingelheim International GmbH. No Rapid Service Fee was received by the journal for the publication of this article. |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Advances in Therapy;38 |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject | Pulmons - Malalties obstructives - Tractament |
dc.subject | Broncodilatadors - Ús terapèutic |
dc.subject.mesh | Pulmonary Disease, Chronic Obstructive |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Treatment Outcome |
dc.subject.mesh | Bronchodilator Agents |
dc.title | Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO® Trials |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s12325-020-01528-2 |
dc.subject.decs | enfermedad pulmonar obstructiva crónica |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | resultado del tratamiento |
dc.subject.decs | broncodilatadores |
dc.relation.publishversion | https://doi.org/10.1007/s12325-020-01528-2 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Rabe KF] LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research (DZL), Grosshansdorf, Germany. Christian Albrechts University Kiel, Airway Research Center North, German Center for Lung Research (DZL), Kiel, Germany. [Chalmers JD] Tayside Respiratory Research Group, University of Dundee, Dundee, UK. [Miravitlles M] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain. [Kocks JWH] General Practitioners Research Institute, Groningen, The Netherlands. Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Observational and Pragmatic Research Institute, Singapore, Singapore. [Tsiligianni I] Health Planning Unit, Department of Social Medicine, Faculty of Medicine, University of Crete, Crete, Greece. [de la Hoz A] Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany |
dc.identifier.pmid | 33175291 |
dc.identifier.wos | 000588599900002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |